Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 21
Filtrar
Más filtros

Banco de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Neth Heart J ; 28(Suppl 1): 50-56, 2020 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-32780332

RESUMEN

In 2011 the Netherlands Heart Foundation allocated funding (CVON, Cardiovasculair Onderzoek Nederland) to stimulate collaboration between clinical and preclinical researchers on specific areas of research. One of those areas involves genetic heart diseases, which are frequently caused by pathogenic variants in genes that encode sarcomere proteins. In 2014, the DOSIS (Determinants of susceptibility in inherited cardiomyopathy: towards novel therapeutic approaches) consortium was initiated, focusing their research on secondary disease hits involved in the onset and progression of cardiomyopathies. Here we highlight several recent observations from our consortium and collaborators which may ultimately be relevant for clinical practice.

2.
Neth Heart J ; 27(4): 206-207, 2019 04.
Artículo en Inglés | MEDLINE | ID: mdl-30895526

RESUMEN

Correction to: Neth Heart J 2019 https://doi.org/10.1007/s12471-019-1239-0 In the version of the article originally published online, there was an error in Fig. 1a. In the 3â€¯× 3 panel, the images indicated as 'CMR cine of four-chamber view', 'Parametric image of k2' and 'Polar map of k2' were ….

3.
Neth Heart J ; 27(4): 200-205, 2019 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-30767167

RESUMEN

AIMS: Previous studies have shown that hypertrophic cardiomyopathy mutation carriers have a decreased myocardial energy efficiency, which is thought to play a key role in the pathomechanism of hypertrophic cardiomyopathy (HCM). The ENERGY trial aims to determine whether metabolic drugs correct decreased myocardial energy efficiency in HCM mutation carriers at an early disease stage. METHODS: 40 genotype-positive, phenotype-negative MYH7 mutation carriers will be treated for two months with trimetazidine or placebo in a double-blind randomised study design. Directly before and after treatment, study subjects will undergo an [11C]-acetate positron emission tomography/computed tomography (PET/CT) and cardiac magnetic resonance (CMR) scan to measure myocardial energy efficiency. Myocardial efficiency will be calculated as the amount of oxygen the heart consumes to perform work. CONCLUSION: The ENERGY trial will be the first proof of concept study to determine whether metabolic drugs are a potential preventive therapy for HCM. Given that trimetazidine is already being used in clinical practice, there is large potential to swiftly implement this drug in HCM therapy.

4.
Neth Heart J ; 29(7-8): 357-358, 2021 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-34143417
5.
Neth Heart J ; 28(6): 299-300, 2020 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-32378128
6.
Neth Heart J ; 26(10): 471-472, 2018 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-30215170
7.
Colloids Surf B Biointerfaces ; 171: 445-450, 2018 Nov 01.
Artículo en Inglés | MEDLINE | ID: mdl-30075420

RESUMEN

Fluorinated-titanium dioxide (TiO2-F) nanoparticles in a pure anatase polymorph was precipitated from solution by hydrolysis of titanium oxychloride, using urea and ammonia as precipitation agents and potassium fluoride as a source of fluorine anion. A further wet attrition milling in presence of glycine completed by a heat treatment allowed an additional nitrogen doping of TiO2 (TiO2-F&N-HT). The morphology and crystalline structure of the as-synthesized powder was determined by transmission electron microscopy (TEM) and X-ray diffraction (XRD) and showed that TiO2 powder was composed of nanoparticles with narrow size distribution which crystallized in the anatase phase. X-ray photoelectron spectroscopy (XPS) revealed that fluorine and nitrogen are present in TiO2 as surface fluorination and interstitial doping, respectively. UV-vis diffuse reflectance spectroscopy (DRS) showed an increased optical absorption in the visible for TiO2-F&N-HT sample. Under visible light irradiation, TiO2-F nanoparticles showed a high photocatalytic performance, showing the high potential of an improved surface fluorination for Escherichia coli (E. coli) disinfection in suspension. These results show the importance of anatase-TiO2 nanoparticles synthesis and modification by using a wet chemical approach leading to low aggregation and high specific surface area for effective bacterial inactivation. The co-doped TiO2-F&N-HT powder showed slightly improved performance compared to the fluorinated sample. The significant degree of aggregation after the heat treatment is postulated as being a limiting factor in its photocatalytic activity.


Asunto(s)
Antibacterianos/química , Luz , Nanopartículas/química , Titanio/química , Antibacterianos/farmacología , Catálisis , Escherichia coli/efectos de los fármacos , Halogenación , Pruebas de Sensibilidad Microbiana , Tamaño de la Partícula , Procesos Fotoquímicos , Propiedades de Superficie , Titanio/farmacología
8.
Spectrochim Acta A Mol Biomol Spectrosc ; 172: 100-108, 2017 Feb 05.
Artículo en Inglés | MEDLINE | ID: mdl-27143534

RESUMEN

Titanium white (TiO2) has been widely used as a pigment in the 20th century. However, its most photocatalytic form (anatase) can cause severe degradation of the oil paint in which it is contained. UV light initiates TiO2-photocatalyzed processes in the paint film, degrading the oil binder into volatile components resulting in chalking of the paint. This will eventually lead to severe changes in the appearance of a painting. To date, limited examples of degraded works of art containing titanium white are known due to the relatively short existence of the paintings in question and the slow progress of the degradation process. However, UV light will inevitably cause degradation of paint in works of art containing photocatalytic titanium white. In this work, a method to detect early warning signs of photocatalytic degradation of unvarnished oil paint is proposed, using atomic force microscopy (AFM) and X-ray photoelectron spectroscopy (XPS). Consequently, a four-stage degradation model was developed through in-depth study of TiO2-containing paint films in various stages of degradation. The XPS surface analysis proved very valuable for detecting early warning signs of paint degradation, whereas the AFM results provide additional confirmation and are in good agreement with bulk gloss reduction.

9.
Cancer Res ; 59(22): 5732-6, 1999 Nov 15.
Artículo en Inglés | MEDLINE | ID: mdl-10582692

RESUMEN

Discrimination between chronic pancreatitis and pancreatic carcinoma can be complicated, particularly in brush cytology specimens. Previous studies have shown that the oxygen insensitivity of the histochemical reaction to detect glucose-6-phosphate dehydrogenase activity based on neotetrazolium reduction can be used for discriminating malignant cells from nonmalignant cells. In the present study, we investigated the value of the assay for differential diagnosis between the two pancreatic diseases. Oxygen insensitivity in ductal epithelial cells in normal human pancreas, chronic pancreatitis, and pancreatic carcinoma was determined by quantitative image analysis in sections of biopsies and in brush cytology preparations. In sections, the reaction in the absence of oxygen was a proper reflection of glucose-6-phosphate dehydrogenase activity, whereas in the presence of oxygen only malignant cells showed a significant reaction. Of 39 brush cytology specimens, diagnosis of all 11 cases of pancreatitis and 28 cases of cancer with the oxygen insensitivity test were in agreement with independent measures of chronic pancreatitis and cancer. The oxygen insensitivity test is a simple and valuable tool in addition to conventional pathology for differential diagnosis between pancreatitis and pancreatic cancer, both in biopsies and in brush cytology specimens.


Asunto(s)
Pruebas Enzimáticas Clínicas/métodos , Glucosafosfato Deshidrogenasa/metabolismo , Oxígeno , Neoplasias Pancreáticas/diagnóstico , Pancreatitis/diagnóstico , Biopsia , Enfermedad Crónica , Diagnóstico Diferencial , Humanos , Oxígeno/metabolismo , Páncreas/metabolismo , Páncreas/patología , Neoplasias Pancreáticas/metabolismo , Neoplasias Pancreáticas/patología , Pancreatitis/metabolismo , Pancreatitis/patología , Sales de Tetrazolio
10.
Free Radic Biol Med ; 23(3): 435-44, 1997.
Artículo en Inglés | MEDLINE | ID: mdl-9214580

RESUMEN

Decreased intracellular SOD protein levels and activity have been related with malignancy in the past. To investigate their relevance in the carcinogenetic process in the colon, we determined quantitatively CuZn-SOD and Mn-SOD levels and total SOD activity by histochemical means in human normal colorectal mucosa, adenomas, and carcinomas. Protein levels and activity were significantly decreased in carcinomas. CuZn-SOD protein levels, but not Mn-SOD levels or total SOD activity were related with differentiation grade and to a lesser extent with Dukes stage. Moderately differentiated carcinomas and Dukes stage A carcinomas showed lowest levels. Some carcinomas expressed elevated levels of CuZn-SOD and this was an indication of poor survival. It is concluded that decreased SOD expression is not a prognostic marker and seems to be a secondary phenomenon rather than directly linked with the carcinogenetic process.


Asunto(s)
Adenocarcinoma/enzimología , Adenoma/enzimología , Neoplasias Colorrectales/enzimología , Superóxido Dismutasa/metabolismo , Adenocarcinoma/patología , Adenoma/patología , Diferenciación Celular , Colon/enzimología , Neoplasias Colorrectales/mortalidad , Neoplasias Colorrectales/patología , Histocitoquímica , Humanos , Inmunohistoquímica , Mucosa Intestinal/patología , Metástasis Linfática , Estadificación de Neoplasias , Pronóstico , Recto/enzimología
11.
J Histochem Cytochem ; 47(5): 575-82, 1999 May.
Artículo en Inglés | MEDLINE | ID: mdl-10219051

RESUMEN

We review here the oxygen insensitivity of the histochemical assay of glucose-6-phosphate dehydrogenase (G6PDH) activity to detect cancer cells. This inexpensive and rapid assay can be performed within half an hour. Discrimination between cancerous and noncancerous cells is based on a combination of elevated G6PDH activity, decreased superoxide dismutase (SOD) activity, and decreased lipid peroxidation in cancer cells. The test discriminates between adenomas and carcinomas of the colon with a certainty of >80% and has a high prognostic value for survival of colon cancer patients. Pancreatitis and pancreatic cancer are discriminated with a certainty of 100%. Therefore, the test can be applied by pathologists to provide additional information in difficult cases of diagnosis of cancer and for prognosis.


Asunto(s)
Glucosafosfato Deshidrogenasa/efectos de los fármacos , Glucosafosfato Deshidrogenasa/metabolismo , Histocitoquímica/métodos , Neoplasias/enzimología , Oxígeno/farmacología , Animales , Colon/enzimología , Colon/patología , Neoplasias Colorrectales/enzimología , Diagnóstico Diferencial , Humanos , Hiperplasia , Mucosa Intestinal/enzimología , Neoplasias Pancreáticas/enzimología , Pancreatitis/enzimología , Valor Predictivo de las Pruebas
12.
J Histochem Cytochem ; 48(10): 1421-30, 2000 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-10990495

RESUMEN

Cathepsin B is a lysosomal cysteine proteinase that may participate in cancer progression. We compared localization of its protein and activity during progression of human colorectal cancer. In adenomas and carcinomas, protein expression and, particularly, activity were elevated compared with those in normal colorectal mucosa. In normal mucosa, cathepsin B protein expression was moderate in stroma and variable in epithelium, whereas activity was mainly present in distinct areas of stroma directly underneath the surface of the colon and in epithelium at the surface of the colon. Stroma in adenomas and carcinomas contained moderate to high protein levels but little activity except for areas of angiogenesis, inflammation, and necrosis, in which activity was high. In adenomas and the majority of well-differentiated carcinomas and moderately differentiated carcinomas, cathepsin B protein and activity were found in granular form in the epithelium, close to the basement membrane. Protein and activity levels were low and diffusely distributed in cancer cells in the remainder of the well-differentiated and moderately differentiated carcinomas and in all poorly differentiated carcinomas. Invasive fronts in most cancers contained moderate protein levels but high activity. We conclude that (a) activity localization is essential to understand the role of cathepsin B in cancer progression, and (b) cathepsin B activity in human colon is associated with invasion of cancer cells, endothelial cells, and inflammatory cells, and in cell death, both apoptotic and necrotic.


Asunto(s)
Catepsina B/metabolismo , Neoplasias Colorrectales/enzimología , Pólipos Adenomatosos/enzimología , Pólipos Adenomatosos/patología , Colon/enzimología , Neoplasias Colorrectales/irrigación sanguínea , Neoplasias Colorrectales/patología , Humanos , Inmunohistoquímica , Inflamación/metabolismo , Mucosa Intestinal/enzimología , Invasividad Neoplásica , Neovascularización Patológica , Recto/enzimología
13.
Arch Ophthalmol ; 110(2): 203-5, 1992 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-1736868

RESUMEN

Twenty-eight paired human corneas were preserved in minimal essential medium at 31 degrees C and in McCarey-Kaufman medium at 4 degrees C. These grafts were then transplanted in pairs of patients with keratoconus who were age matched as closely as possible. These pairs received donor corneas from the same donor, so for each pair the donor age and time from death to preservation were the same. Visual acuity, central corneal thickness, and endothelial cell counts were compared. During the 1- to 2-year study period, no statistically significant difference in visual acuity, corneal thickness, or endothelial cell density was found between grafts stored in minimal essential medium and those stored in McCarey-Kaufman medium.


Asunto(s)
Córnea/fisiología , Trasplante de Córnea , Técnicas de Cultivo de Órganos , Preservación de Órganos/métodos , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Recuento de Células , Criopreservación , Medios de Cultivo , Endotelio Corneal , Estudios de Seguimiento , Supervivencia de Injerto , Humanos , Queratocono/cirugía , Persona de Mediana Edad , Compuestos Orgánicos , Estudios Prospectivos , Temperatura , Agudeza Visual
14.
Neth Heart J ; 12(3): 117-120, 2004 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-25696309

RESUMEN

A female patient, 36 years of age, with a metastasised left breast cancer received several courses of chemotherapy for aggressive local tumour growth and multiple metastatic activity. In the current patient, surgical ablation of the left breast was carried out. Also loco-regional radio-therapy was conducted. To facilitate the administration of chemotherapy courses and prevent thrombophlebitis a vascular access port (port-a-cath) was surgically inserted via the right subclavian vein. After a few successful administrations of chemotherapeutic drugs the vascular port stopped functioning. It was demonstrated that a detached catheter fragment had dislodged into the right ventricle. Successful percutaneous, transvenous removal of the entrapped catheter fragment by the Gooseneck retrieval loop snare from the right ventricle was performed via the right femoral vein access. The procedure was uncomplicated and the patient tolerated the procedure well.

17.
Doc Ophthalmol ; 67(1-2): 145-50, 1987.
Artículo en Inglés | MEDLINE | ID: mdl-2448102

RESUMEN

In 1986, conjunctival transplantations were performed on 54 patients. Patients with severe corneal ulcers, who did not react adequately to local therapy, formed the largest group who were treated in this way, in particular patients in whom the prognosis for a perforating corneal graft was poor. Other indications are: bullous keratopathy, pterygium, trauma, symblepharon, etc,. In general other forms of therapy are tried first before conjunctival transplantations are performed.


Asunto(s)
Conjuntiva/trasplante , Enfermedades de la Córnea/terapia , Úlcera de la Córnea/terapia , Enfermedades de la Córnea/patología , Úlcera de la Córnea/patología , Humanos , Cuidados Paliativos , Pterigion/terapia , Colgajos Quirúrgicos
18.
Cytometry ; 38(4): 176-83, 1999 Aug 15.
Artículo en Inglés | MEDLINE | ID: mdl-10440855

RESUMEN

Prognosis of colorectal cancer patients that show similar histopathology may vary substantially. An attempt was made to improve prognosis by the self-learning classification program CLASSIF1, based on automated multiparameter analysis of quantitative histochemical and clinical parameters of 64 colorectal carcinomas and adjacent normal mucosae. The histochemical parameters applied were the oxygen-insensitivity assay of glucose-6-phosphate dehydrogenase (G6PDH) activity, a valid discriminator between normal and cancerous mucosae, and related parameters CuZn- and Mn-superoxide dismutase (SOD) levels, and lipid peroxidation (LPO) capacity. Data were processed on the basis of a postoperative follow-up of minimally 32 and maximally 56 months. CLASSIF1 selected the parameters oxygen insensitivity of G6PDH activity, CuZn-SOD and Mn-SOD levels, LPO capacity, lymph node metastasis, Dukes' stage, and age for the highest prognostic value. On the basis of these selected parameters, CLASSIF1 correctly predicted favorable outcome in 100% of the surviving patients and fatal outcome in 64% of the deceased patients. G6PDH activity appeared to be the major information carrier for CLASSIF1. On the basis of G6PDH activity parameters alone, 96% of the surviving patients and 55% of the deceased patients were correctly classified. In comparison, estimation of prognosis on the basis of Dukes' stage alone resulted in 71% correctly classified surviving patients and 61% of patients who died. It is concluded that the self-learning classification program CLASSIF1, on the basis of quantitative histochemical and clinical parameters, is the best prognostic estimator for colon cancer patients yet available.


Asunto(s)
Carcinoma/enzimología , Neoplasias Colorrectales/enzimología , Procesamiento Automatizado de Datos/métodos , Glucosafosfato Deshidrogenasa/análisis , Proteínas de Neoplasias/análisis , Superóxido Dismutasa/análisis , Adulto , Anciano , Anciano de 80 o más Años , Carcinoma/mortalidad , Carcinoma/patología , Estudios de Cohortes , Colon/química , Neoplasias Colorrectales/mortalidad , Neoplasias Colorrectales/patología , Femenino , Estudios de Seguimiento , Humanos , Inmunohistoquímica , Peroxidación de Lípido , Masculino , Persona de Mediana Edad , Pronóstico , Recto/química
19.
Cancer Immunol Immunother ; 37(1): 7-14, 1993 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-8513455

RESUMEN

Therapy with repeated intratumoral and perilymphatic administration of relatively low doses of polyethylene-glycol(PEG)-modified interleukin-2 (IL-2) in the syngeneic guinea pig line 10 (L10) hepatocarcinoma results in significant local tumor growth inhibition and a delay in development of regional lymph node metastases of more than 3 weeks when compared to controls. Occasionally animals are cured of tumor. The mechanism of this antitumor activity was studied. The antitumor activity of locoregionally administered PEG-IL-2 was abrogated by pretreatment with polyclonal anti-thymocyte serum, indicating that the observed tumor growth inhibition was a T-cell-mediated phenomenon. Besides the locoregional tumor growth inhibition, a systemic effect was recorded as the growth of a second tumor cell inoculum at the contralateral side was inhibited as well. Furthermore, those animals cured after PEG-IL-2 therapy developed specific immunity against the L10 tumor and this immunity could be transferred to naive animals by spleen cells. Immunohistological observations of the tumor site revealed a slight increase of helper and cytotoxic T cell subpopulations after PEG-IL-2 therapy. More pronounced, however, was the rise in number of eosinophilic granulocytes present in the stroma surrounding the tumor cells. Involvement of cytotoxic cells in the antitumor effects of PEG-IL-2 could not be demonstrated: regional lymph node cells and spleen cells obtained immediately after therapy (day 15) or on day 21 showed no cytotoxic activity in vitro against L10, K562, Daudi and line 1 (L1) target cells. In conclusion, locoregional therapy with PEG-IL-2 induced a a systemic T-cell-mediated antitumor response. As no cytotoxic T cell activity was measured, however, the underlying mechanism is most likely a T-helper response. Eosinophils at the tumor site may be tumoricidal but further experiments must reveal the role of these cells in the PEG-IL-2-induced tumor regression.


Asunto(s)
Interleucina-2/análogos & derivados , Neoplasias Hepáticas Experimentales/terapia , Subgrupos de Linfocitos T/efectos de los fármacos , Animales , Antígenos de Neoplasias/inmunología , Moléculas de Adhesión Celular Neuronal/inmunología , Pruebas Inmunológicas de Citotoxicidad , Femenino , Fibrosis/tratamiento farmacológico , Granulocitos/efectos de los fármacos , Cobayas , Inmunidad Celular , Inmunohistoquímica , Inmunoterapia Adoptiva , Inyecciones Intralesiones , Inyecciones Intralinfáticas , Interleucina-2/administración & dosificación , Interleucina-2/farmacología , Interleucina-2/uso terapéutico , Complejo de Antígeno L1 de Leucocito , Neoplasias Hepáticas Experimentales/inmunología , Neoplasias Hepáticas Experimentales/patología , Metástasis Linfática/inmunología , Metástasis Linfática/prevención & control , Masculino , Trasplante de Neoplasias , Polietilenglicoles , Inducción de Remisión , Neoplasias del Bazo/inmunología , Neoplasias del Bazo/prevención & control , Neoplasias del Bazo/secundario , Subgrupos de Linfocitos T/inmunología
20.
J Pathol ; 182(4): 398-403, 1997 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-9306960

RESUMEN

The effects of oxygen on the quantitative histochemical assay to detect glucose-6-phosphate dehydrogenase (G6PDH) activity based on neotetrazolium reduction were studied in the different stages of carcinogenesis in the colon. Normal and hyperplastic epithelium, mucosae of patients with active Crohn's disease, and adenomas and adenocarcinomas of the colon were used. Epithelium of normal and inflamed mucosa, and hyperplastic epithelium, showed a residual G6PDH activity (RA) in oxygen that was always less than 20 per cent of the activity in the absence of oxygen. In adenomas and in dysplastic epithelia adjacent to carcinomas, the RA was significantly higher than that in normal epithelium, but significantly lower than that in adenocarcinomas. The RA of adenomas never exceeded 35 per cent. The RA of adenocarcinomas was on average 53 per cent and always higher than 20 per cent. When 35 per cent was used as a cut-off level, the sensitivity of RA to diagnose malignancy was 96.5 per cent. In a parallel study, a mouse model was used in which colon carcinomas and their precursors were induced chemically. Development of oxygen insensitivity during chemically induced carcinogenesis showed a pattern similar to that observed in the human. In conclusion, the test to determine RA is a useful tool for the detection of malignant mucosa in the colon. The test is particularly helpful in addition to histopathology for the detection of small lesions and the early stages of cancer.


Asunto(s)
Adenocarcinoma/enzimología , Adenoma/enzimología , Neoplasias del Colon/enzimología , Pólipos del Colon/enzimología , Glucosafosfato Deshidrogenasa/análisis , Oxígeno/metabolismo , Lesiones Precancerosas/enzimología , Adenocarcinoma/diagnóstico , Adenoma/diagnóstico , Análisis de Varianza , Animales , Colon/enzimología , Neoplasias del Colon/diagnóstico , Pólipos del Colon/diagnóstico , Enfermedad de Crohn/diagnóstico , Enfermedad de Crohn/enzimología , Dimetilhidrazinas , Femenino , Glucosafosfato Deshidrogenasa/metabolismo , Histocitoquímica , Hiperplasia , Mucosa Intestinal/enzimología , Ratones , Ratones Mutantes , Lesiones Precancerosas/diagnóstico , Valor Predictivo de las Pruebas
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA